These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 24421172)

  • 1. Incorporating a right to health perspective into the resolution of patent law disputes.
    Oke EK
    Health Hum Rights; 2013 Dec; 15(2):97-109. PubMed ID: 24421172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Taking TRIPS to India--Novartis, patent law, and access to medicines.
    Mueller JM
    N Engl J Med; 2007 Feb; 356(6):541-3. PubMed ID: 17287473
    [No Abstract]   [Full Text] [Related]  

  • 3. Right to health encompasses right to access essential generic medicines: challenging the 2008 Anti-Counterfeit Act in Kenya.
    Maleche A; Day E
    Health Hum Rights; 2014 Dec; 16(2):E96-E104. PubMed ID: 25569728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Access to life-saving medicines and intellectual property rights: an ethical assessment.
    Schroeder D; Singer P
    Camb Q Healthc Ethics; 2011 Apr; 20(2):279-89. PubMed ID: 21435303
    [No Abstract]   [Full Text] [Related]  

  • 5. Why are generic drugs being held up in transit? Intellectual property rights, international trade, and the right to health in Brazil and beyond.
    Rosina MS; Shaver L
    J Law Med Ethics; 2012; 40(2):197-205. PubMed ID: 22789040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patents and the obligation to protect health: examining the significance of human rights considerations in the protection of pharmaceutical patents.
    Owoeye OA
    J Law Med; 2014 Jun; 21(4):900-19. PubMed ID: 25087369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patents and human rights: a heterodox analysis.
    Gold ER
    J Law Med Ethics; 2013; 41(1):185-98. PubMed ID: 23581665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Has the implementation of the TRIPS Agreement in Latin America and the Caribbean produced intellectual property legislation that favours public health?
    Oliveira MA; Bermudez JA; Chaves GC; Velásquez G
    Bull World Health Organ; 2004 Nov; 82(11):815-21. PubMed ID: 15640916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amendments to the Canadian Patent Act to address drug access: is help on the way?
    Penner MD; Narayanan P
    Food Drug Law J; 2005; 60(3):459-70. PubMed ID: 16304751
    [No Abstract]   [Full Text] [Related]  

  • 10. Expanding Access and Reducing Prices for Drugs to Prevent HIV: Should Government Enforce Its Patent Rights Against the Pharmaceutical Industry?
    Gostin LO; Rai AK
    JAMA; 2020 Mar; 323(9):821-822. PubMed ID: 32125411
    [No Abstract]   [Full Text] [Related]  

  • 11. Patents and access to essential drugs.
    Loff B
    Trans R Soc Trop Med Hyg; 2003; 97(1):6-9. PubMed ID: 12886793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How do public health safeguards in Indian patent law affect pharmaceutical patenting in practice?
    Sampat BN; Amin T
    J Health Polit Policy Law; 2013 Aug; 38(4):735-55. PubMed ID: 23645877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Introduction: Access to life-saving medicines and intellectual property rights.
    Schroeder D
    Camb Q Healthc Ethics; 2011 Apr; 20(2):277-8. PubMed ID: 21435302
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmaceutical patent law: the Canadian perspective.
    Aumand L; Norman J
    Pharm Pat Anal; 2016 Jul; 5(4):271-9. PubMed ID: 27346187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Several timely health law topics. Foreword.
    Coker KL; Singer L; Blum J
    Ann Health Law; 2010; 19(2):i-iii. PubMed ID: 21443145
    [No Abstract]   [Full Text] [Related]  

  • 16. Academic patents and access to medicines in developing countries.
    Sampat BN
    Am J Public Health; 2009 Jan; 99(1):9-17. PubMed ID: 19008514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patent law--balancing profit maximization and public access to technology.
    Beckerman-Rodau A
    Columbia Sci Technol Law Rev; 2003; 4():E1. PubMed ID: 15977333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unsettling drug patent settlements: a framework for presumptive illegality.
    Carrier MA
    Mich Law Rev; 2009 Oct; 108(1):37-80. PubMed ID: 20535881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health rights litigation and access to medicines: priority classification of successful cases from Costa Rica's constitutional chamber of the Supreme Court.
    Norheim OF; Wilson BM
    Health Hum Rights; 2014 Dec; 16(2):E47-61. PubMed ID: 25569724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effects of Intellectual Property Rights on Access to Medicines and Catastrophic Expenditure.
    Jung Y; Kwon S
    Int J Health Serv; 2015; 45(3):507-29. PubMed ID: 26077858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.